A Case of Remnant Gastric Cancer with Mesojejunal Lymph Node Metastasis

Hiromichi Sasaki; Takeshi Aoki; Akihiro Yamamura; Naoki Tanaka; Hirofumi Imoto; Takahiro Tsuchiya; Tomomi Kawana; Takanori Morikawa; Shinobu Ohnuma; Takashi Kamei; Michiaki Unno

A Case of Remnant Gastric Cancer with Mesojejunal Lymph Node Metastasis

Hiromichi Sasaki, Takeshi Aoki, Akihiro Yamamura, Naoki Tanaka, Hirofumi Imoto, Takahiro Tsuchiya, Tomomi Kawana, Takanori Morikawa, Shinobu Ohnuma, Takashi Kamei, Michiaki Unno

Research output: Contribution to journal › Article › peer-review

Abstract

A 62-year-old man underwent radical surgery for the treatment of remnant gastric cancer with mesojejunal lymph node metastasis. According to the 15th edition of the Japanese Gastric Cancer Association, a histological diagnosis of B-35-A, type 3, tub2>tub1, pT3(SS), pN3a(10/37), cM0, CY0, pStage ⅢB was made. All lymph node metastases were recognized in the mesojejunum. Adjuvant chemotherapy with S-1 plus docetaxel was initiated after 4 weeks of surgery. The patient is still alive without recurrence after 1 year of surgery. Thus, radical surgery with dissection of the mesojejunum and intensive adjuvant chemotherapy might improve the prognosis in a remnant gastric cancer patient with mesojejunal lymph node metastasis.

Original language	English
Pages (from-to)	2118-2120
Number of pages	3
Journal	Gan to kagaku ryoho. Cancer & chemotherapy
Volume	48
Issue number	13
Publication status	Published - 2021 Dec 1

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{75effed40f304023be8438047a269fd6,

title = "A Case of Remnant Gastric Cancer with Mesojejunal Lymph Node Metastasis",

abstract = "A 62-year-old man underwent radical surgery for the treatment of remnant gastric cancer with mesojejunal lymph node metastasis. According to the 15th edition of the Japanese Gastric Cancer Association, a histological diagnosis of B-35-A, type 3, tub2>tub1, pT3(SS), pN3a(10/37), cM0, CY0, pStage ⅢB was made. All lymph node metastases were recognized in the mesojejunum. Adjuvant chemotherapy with S-1 plus docetaxel was initiated after 4 weeks of surgery. The patient is still alive without recurrence after 1 year of surgery. Thus, radical surgery with dissection of the mesojejunum and intensive adjuvant chemotherapy might improve the prognosis in a remnant gastric cancer patient with mesojejunal lymph node metastasis.",

author = "Hiromichi Sasaki and Takeshi Aoki and Akihiro Yamamura and Naoki Tanaka and Hirofumi Imoto and Takahiro Tsuchiya and Tomomi Kawana and Takanori Morikawa and Shinobu Ohnuma and Takashi Kamei and Michiaki Unno",

year = "2021",

month = dec,

day = "1",

language = "English",

volume = "48",

pages = "2118--2120",

journal = "Japanese Journal of Cancer and Chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "13",

}

TY - JOUR

T1 - A Case of Remnant Gastric Cancer with Mesojejunal Lymph Node Metastasis

AU - Sasaki, Hiromichi

AU - Aoki, Takeshi

AU - Yamamura, Akihiro

AU - Tanaka, Naoki

AU - Imoto, Hirofumi

AU - Tsuchiya, Takahiro

AU - Kawana, Tomomi

AU - Morikawa, Takanori

AU - Ohnuma, Shinobu

AU - Kamei, Takashi

AU - Unno, Michiaki

PY - 2021/12/1

Y1 - 2021/12/1

N2 - A 62-year-old man underwent radical surgery for the treatment of remnant gastric cancer with mesojejunal lymph node metastasis. According to the 15th edition of the Japanese Gastric Cancer Association, a histological diagnosis of B-35-A, type 3, tub2>tub1, pT3(SS), pN3a(10/37), cM0, CY0, pStage ⅢB was made. All lymph node metastases were recognized in the mesojejunum. Adjuvant chemotherapy with S-1 plus docetaxel was initiated after 4 weeks of surgery. The patient is still alive without recurrence after 1 year of surgery. Thus, radical surgery with dissection of the mesojejunum and intensive adjuvant chemotherapy might improve the prognosis in a remnant gastric cancer patient with mesojejunal lymph node metastasis.

AB - A 62-year-old man underwent radical surgery for the treatment of remnant gastric cancer with mesojejunal lymph node metastasis. According to the 15th edition of the Japanese Gastric Cancer Association, a histological diagnosis of B-35-A, type 3, tub2>tub1, pT3(SS), pN3a(10/37), cM0, CY0, pStage ⅢB was made. All lymph node metastases were recognized in the mesojejunum. Adjuvant chemotherapy with S-1 plus docetaxel was initiated after 4 weeks of surgery. The patient is still alive without recurrence after 1 year of surgery. Thus, radical surgery with dissection of the mesojejunum and intensive adjuvant chemotherapy might improve the prognosis in a remnant gastric cancer patient with mesojejunal lymph node metastasis.

UR - http://www.scopus.com/inward/record.url?scp=85123813507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123813507&partnerID=8YFLogxK

M3 - Article

C2 - 35045511

AN - SCOPUS:85123813507

SN - 0385-0684

VL - 48

SP - 2118

EP - 2120

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

IS - 13

ER -

A Case of Remnant Gastric Cancer with Mesojejunal Lymph Node Metastasis

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this